Back to Authors

Roberts, Rosebud O.

A5112116344 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 223

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

Neurology | December 19, 2013 | Volume: 82 | Issue: 4 | Pages: 317-325

10.1212/wnl.0000000000000055 | PMID 24353333

Subtle gait changes in patients with REM sleep behavior disorder

Movement Disorders | October 15, 2013 | Volume: 28 | Issue: 13 | Pages: 1847-1853

10.1002/mds.25653 | PMID 24130124

ABSTRACT Many people with rapid eye movement (REM) sleep behavior disorder (RBD) have an underlying synucleinopathy, the most common of which is Lewy body disease. Identifying additional abnormal clinical features may help in identifying those at greater risk of evolving to a more severe syndrome. Because gait disorders are common in the synucleinopathies, early abnormalities in gait in those with RBD could help in identifying those at increased risk of developing overt parkinsonism and/or cognitive impairment. We identified 42 probable RBD subjects and 492 controls using the Mayo Sleep Questionnaire and assessed gait velocity, cadence, and stride dynamics with an automated gait analysis system. Cases and controls were similar in age (79.9 ± 4.7 and 80.1 ± 4.7, P = 0.74), Unified Parkinson's Disease Rating Scale Part III (UPDRS) score (3.3 ± 5.5 and 1.9 ± 4.1, P = 0.21) and Mini–Mental State Examination scores (27.2 ± 1.9 and 27.7 ± 1.6, P = 0.10). A diagnosis of probable RBD was associated with decreased velocity (−7.9 cm/s; 95% confidence interval [CI], −13.8 to −2.0; P < 0.01), cadence (−4.4 steps/min; 95% CI, −7.6 to −1.3; P < 0.01), significantly increased double limb support variability (30%; 95% CI, 6–60; P = 0.01), and greater stride time variability (29%; 95% CI, 2–63; P = 0.03) and swing time variability (46%; 95% CI, 15–84; P < 0.01). Probable RBD is associated with subtle gait changes prior to overt clinical parkinsonism. Diagnosis of probable RBD supplemented by gait analysis may help as a screening tool for disorders of α‐synuclein. © 2013 International Parkinson and Movement Disorder Society
O4–02–05: Combinations of amyloid and neurodegeneration biomarkers have a differential impact on cognition

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2013.04.344

S1–02–01: Epidemiology of mild cognitive impairment: The Mayo Clinic Study of Aging

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2013.04.036

IC‐P‐027: Association between head trauma, amyloid and neurodegeneration in a population‐based study of cognitively normal and mild cognitive impairment participants

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.028

P4–004: Association study of late‐onset Alzheimer's disease risk variants and memory decline

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2013.05.1392

P3–173: Association between head trauma, amyloid, and neurodegeneration in a population‐based study of cognitively normal participants and participants with mild cognitive impairment

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2013.05.1245

IC‐P‐028: CogState computerized testing is associated with amyloid and FDG‐PET: Implications for secondary preventive trials

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.029

P3–217: Effect of intellectual lifestyle and Alzheimer's disease biomarkers on rate of cognitive decline: Mayo Clinic Study of Aging

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2013.05.1290

P4–240: Practice effects and longitudinal cognitive change in normal aging versus incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2013.05.1632